Medication Safety Issues
Sound-alike/look-alike issues:
Dinutuximab may be confused with daratumumab, denosumab, dinutuximab beta (available internationally), dostarlimab, durvalumab, isatuximab, loncastuximab tesirine, margetuximab, obinutuzumab, rituximab.
High-alert medication:
The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes (chemotherapeutic agent, parenteral and oral) which have a heightened risk of causing significant patient harm when used in error (High-Alert Medications in Acute Care, Community/Ambulatory Care, and Long-Term Care Settings).